Why the study?
Do novel technologies (CARTO3, PVAC, Sensei robotic system) improve arrhythmia-free survival and reduce procedural times compared to the older CARTO XP system in patients undergoing ablation for paroxysmal atrial fibrillation?
Cohort (n=312)
No
Do novel technologies (CARTO3, PVAC, Sensei robotic system) improve arrhythmia-free survival and reduce procedural times compared to the older CARTO XP system in patients undergoing ablation for paroxysmal atrial fibrillation?
Absolute Event Rate: 76.1% vs 65.8%
p-value: p=<0.01
The use of newer technologies like CARTO3 and robotic navigation for pulmonary vein isolation significantly improves arrhythmia-free survival and reduces procedural and fluoroscopic times compared to older mapping systems.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bulava et al. (2012) conducted a cohort in Paroxysmal atrial fibrillation (n=312). Novel ablation technologies (CARTO3, PVAC, Sensei robotic system) vs. CARTO XP (older 3D mapping system) was evaluated on Arrhythmia-free survival at 12 months (p=<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: